Delivery Order SPE2DB20D1100-SPE2DB25FC1H2
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$44K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,494.05 contract is for the supply of 4,567,951,867 units of the diabetes medication Jardiance 25 mg tablets. The award has an ultimate completion date of April 18, 2025 and was made on April 17, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,395.70, is for the supply of 4,568,142,300 units of the diabetes medication Jardiance 25 mg tablets. The contract has a performance period through May 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,996,072 units of the diabetes medication Jardiance 25 mg tablets. The contract has a ceiling value of $25,342.73 and a period of performance through April 23, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,876.74, is for the delivery of 4,567,957,360 units of the diabetes medication Jardiance 25 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is not set aside for a specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $38,548.22 and has an ultimate completion date of April 30, 2025. It is for the provision of 4,568,076,618 units of the diabetes medication Jardiance 25 mg tablet in 90-count packages. The contract is not set-aside and represents an open competition award. AmerisourceBergen Drug...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,369.07, is for the delivery of 4,568,077,683 units of the diabetes medication Jardiance 10 mg tablets. The contract has an ultimate completion date of April 30, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,145.46 firm-fixed-price contract is for the delivery of 4,568,175,187 units of the diabetes medication Jardiance 25 mg tablets. The contract has a period of performance through May 8, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $10,735.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,013,835 units of the diabetes medication Jardiance 25 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $20,832.54 contract is for the supply of Jardiance 10 mg tablets, a diabetes medication. The award has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a $2,040.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count tablets of the diabetes medication Jardiance 10 mg. It has a period of performance through June 9, 2025 and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...